Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat

Endocrinology

Volumn 137, Issue 3, 1996, Pages 918-924

  Crippes, Barbara A ^a   Engleman, V Wayne ^a   Settle, Steven L ^a   Delarco, Joseph ^a   Ornberg, Richard L ^b   Helfrich, Miep H ^c   Horton, Michael A ^d   Nickols, G Allen ^a  

^a PFIZER INC   (United States)

^b MONSANTO COMPANY   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCITONIN; CALCIUM ION; ECHISTATIN; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F11; PARATHYROID HORMONE RELATED PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CELL ADHESION; CONTROLLED STUDY; HYPOCALCEMIA; LONG BONE; MALE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THYROPARATHYROIDECTOMY; ANIMAL; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PARATHYROIDECTOMY; PATHOLOGY; SPRAGUE DAWLEY RAT; THYROIDECTOMY;

ANIMALS; ANTIBODIES; ANTIGENS, CD; BASE SEQUENCE; BONE RESORPTION; INTEGRIN BETA3; MALE; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; PARATHYROIDECTOMY; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; THYROIDECTOMY;

EID: 85047678341     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.3.8603604     Document Type: Article

References (39)

1. Hynes RO 1987 Integrins: a family of cell surface receptors. Cell 48:549-554
2. Albelda SM, Buck CA 1990 Integrins and other cell adhesion molecules. FASEB J 4:2868-2880
3. Hynes RO 1992 Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
4. Ruoslahti E, Pierschbacher MD 1987 New perspectives in cell adhesion: RGD and integrins. Science 238:491-497
5. 1 integrins. J Biol Chem 268:16737-16745
6. Clover J, Dodds RA, Gowen M 1992 Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J Cell Sci 103:267-271
7. Horton MA, Davies J 1989 Perspectives: adhesion receptors in bone. J Bone Miner Res 4:803-807
8. Hughes DE, Salter DM, Dedhar S, Simpson R 1993 Integrin expression in human bone. J Bone Miner Res 8:527-533
9. Flores ME, Norgård M, Heinegård D, Reinholt F, Andersson G 1992 RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 201:526-530
10. 3 potentiate bone resorption. J Biol Chem 268:9901-9907
11. 3 integrin. J Bone Miner Res 7:335-343
12. 3 integrin subunits in rat osteoclasts in situ. J Bone Miner Res 8:403-413
13. 3 integrin is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cells. Exp Cell Res 182:645-652
14. Cheresh DA 1987 Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84:6471-6475
15. Horton M 1990 Vitronectin receptor: tissue specific expression or adaptation to culture? Int J Exp Pathol 71:741-759
16. Horton MA, Taylor ML, Arnett TR, Helfrich MH 1991 Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195:368-375
17. Chambers TJ, Fuller K, Darby JA, Pringle JAS, Horton MA 1986 Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner 1:127-135
18. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ 1990 Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713-1723
19. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Väänänen HK 1991 Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol 115:1179-1186
20. 3. J Bone Miner Res 7:345-351
21. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M 1993 Inhibition of osteoclastic bone resorption in vivo by echistatin, an "Arginyl-Glycly-Aspartyl" (RGD)-containing protein. Endocrinology 132:1411-1413
22. King K, D'Anza JJ, Bodary SC, Pitti R, Siegel M, Lazarus RA, Dennis MS, Hammonds RG, Kukreja SC 1994 The effects of kistrin on bone resorption in vitro and in vivo. J Bone Miner Res 9:381-387
23. Kukreja SC, D'Anza JJ, Lazarus R, Dennis M, Hammonds Jr RG, 1992 Effects of kistrin on serum calcium in normal and hypercalcemic mice. J Bone Miner Res [Suppl 1] 7:S129
24. Horton MA, Dorey EL, Nesbitt SA, Samanen J, Ali FE, Stade JM, Nichols A, Greig R, Helfrich MH 1993 Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J Bone Miner Res 8:239-247
25. Garsky VM, Lumma PK, Freidinger RM, Pitzenberger SM, Randall WC, Veber DF, Gould RJ, Friedman PA 1989 Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs. Proc Natl Acad Sci USA 86:4022-4026
26. Chambers TJ, Magnus CJ 1982 Calcitonin alters behavior of isolated osteoclasts. J Pathol 136:27-39
27. Barka A, Anderson PJ 1962 Histochemical method for acid phosphatase using hexazonium pararosanilin as coupler. J Histochem Cytochem 10:741-753
28. Hock JM, Cain R, Mazur C, Tschopp J 1994 Inhibition of PTH-induced hypercalcemia by a synthetic RGD-containing peptide in an indirect in vivo bone resorption assay. Bone Miner [Suppl 1] 25S44-S45
29. Faint RW 1992 Platelet-neutrophil interactions: their significance. Blood Rev 6:83-91
30. Henson PM 1990 Interactions between neutrophils and platelets. Lab Invest 62:391-393
31. Kaye M 1984 When is it an osteoclast? J Clin Pathol 37:398-400
32. Phillips DR, Charo IF, Parise LV, Fitzgerald LA 1988 The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831-843
33. Gartner TK, Bennet JS 1985 The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 260:11891-11894
34. Pierschbacher MD, Ruoslahti E 1984 Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33
35. Reinholt FP, Hultenby K, Oldberg A, Heinegård D 1990 Osteopontin-a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475
36. Lakkakorpi P, Tuukkanen J, Hentunen T, Järvelin K, Väänänen K 1989 Organization of osteoclast microfilaments during the attachment to bone surface in vitro J Bone Miner Res 4:817-825
37. McKee MD, Nanci A 1993 Ultrastructural, cytochemical and immunocytochemical studies on bone and its surfaces. Cells Materials 3:219-243
38. Sumitani K, Hammonds Jr RG, Lazarus RA, Dennis MS, Mosely JM, Evely RS, Martin TJ 1991 Kistrin inhibits bone resorption and osteoclast formation in vitro. J Bone Miner Res [Suppl 1] 6:S148
39. Tanaka H, Sato M, Shinar D, Rodan GA 1991 Echistatin inhibits osteoclast-like cell generation in the co-culture system of mouse osteoblastic cells and bone marrow cells. J Bone Miner Res [Suppl 1] 6:S148